- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03276234
Is There a Relationship Between Serum Sodium Level and Mean Platelet Volume (MPV) Value
September 12, 2017 updated by: Hakan Tapar, Tokat Gaziosmanpasa University
Is There a Relationship Between Serum Sodium Level and Mean Platelet Volume (MPV) Value in Patients Undergoing Transurethral Prostate Resection (TUR)?
Is there a relationship between serum sodium level and mean platelet volume (MPV) value in patients undergoing transurethral prostate resection (TUR)?
Study Overview
Status
Unknown
Detailed Description
Thirty one patients undergoing transurethral prostate resection (TUR)?
will be evaluated.The relationship between serum sodium value and MPV value of patients will be evaluated.
Study Type
Observational
Enrollment (Anticipated)
31
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hakan Tapar
- Phone Number: 3496 03562129500
- Email: hakantapar@hotmail.com
Study Locations
-
-
-
Tokat, Turkey
- Recruiting
- Male patients between 18 and 80 years of age who have undergone TUR.
-
Contact:
- Hakan Tapar
- Phone Number: 03562129500
- Email: hakantapar@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Probability Sample
Study Population
Male patients who will be done TUR.
Description
Inclusion Criteria:
- American Society of Anesthesiologist (ASA) physical status 1 and 3
- Patients between the ages of 18 and 80
Exclusion Criteria:
- Patients with bleeding disorder
- Patients with blood transfusion
- Patients are that sodium values are lower than normal range.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean platelet volume
Time Frame: one month
|
Changes in mean platelet volüme according to sodium value(Measurements of changes will be made twice in the study framework)
|
one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 13, 2017
Primary Completion (Anticipated)
November 1, 2017
Study Completion (Anticipated)
November 29, 2017
Study Registration Dates
First Submitted
September 6, 2017
First Submitted That Met QC Criteria
September 6, 2017
First Posted (Actual)
September 8, 2017
Study Record Updates
Last Update Posted (Actual)
September 13, 2017
Last Update Submitted That Met QC Criteria
September 12, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 17-KAEK-075
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.